All Bacteria articles – Page 4
-
NewsScientist who harnesses bacteria to deliver green solutions is winner in 2025 Tata Transformation Prize
A scientist who harnesses bacteria to deliver green solutions has been named as one of the winners of the 2025 Tata Transformation Prize. Balasubramanian Gopal, PhD, Indian Institute of Science, has been named Sustainability Winner in the awards.
-
NewsResearchers expand virus-based treatment options for antibiotic-resistant infections
Phages are extremely specific about which strains of a bacterial species they will attack. This has limited their effectiveness against the most antibiotic-resistant strains. To overcome this problem, the research team “trained” the phages by allowing them to evolve together with the bacteria in a controlled laboratory setting for 30 days.
-
NewsPhase 2 clinical trial results show potential to shorten TB treatment time
New clinical trial results show that the novel antibiotic candidate sorfequiline (TBAJ-876), a next-generation diarylquinoline, has the potential to improve tuberculosis (TB) treatment when combined with pretomanid and linezolid in a treatment regimen known as “SPaL.”
-
OpinionThe politics behind the global divide in bacteriophage therapy
The therapeutic potential of bacteriophages (or ‘phages’) has been widely dismissed for decades in the West, despite being regularly used to treat patients worldwide in the early and mid-20th century. In an age rife with disinformation, can the true potential of clinical phage technology be communicated to a public already uneasy about scientific intervention?
-
NewsA microbial blueprint for climate-smart cows
Recent research has shown that feeding cows red seaweed can dramatically cut the amount of methane that is produced and released into the environment. A new study sheds light on that process and reveals which microbes in the cow’s gut might help reduce methane.
-
NewsSugar transporter discovery offers promising avenue for improving antibiotic efficacy
Scientists have recently demonstrated that aminoglycosides enter bacteria by using sugar transporters. They have also successfully doubled the number of transporters, even in the most resistant Escherichia coli strains, thus improving antibiotics’ penetration rate and efficacy.
-
NewsA new gateway to global antimicrobial resistance data
To support global AMR research, EMBL’s European Bioinformatics Institute (EMBL-EBI) has launched the AMR portal, a central hub that connects bacterial genomes, resistance phenotypes, and functional annotations, all in one place. The AMR portal ensures long-term availability, standardisation, and reusability of AMR data.
-
NewsMicrobial teamwork slashes uranium pollution in just 48 hours
A research team has developed a synthetic microbial consortium that completely reduces soluble uranium [U(VI)] to insoluble U(IV) within 48 hours, showing nearly twice the efficiency of a single-strain system. The study reveals how Shewanella oneidensis MR-1 and Pseudomonas aeruginosa LXZ1 cooperate to accelerate extracellular electron transfer (EET).
-
CareersSummer studentship: Megan investigates the mobile gene element that gives MRSA its clout
Megan Stenton reports back on her AMI-sponsored summer studentship which investigated the frequency of the SCCmec gene - a mobile gene element that houses the methicillin resistance gene - across members of the same species of Staphylococcus aureus.
-
NewsAMI warns that the threat of antimicrobial resistance in viruses and other pathogens cannot be underestimated
Applied Microbiology International (AMI) has urged global policymakers to strengthen the revised Global Action Plan on Antimicrobial Resistance (GAP-AMR), calling for a more inclusive, clear and equitable approach to tackling one of the world’s most urgent health challenges.
-
NewsTraces of bacteria inside brain tumors may affect tumor behavior
Scientists have uncovered unexpected traces of bacteria within brain tumors. This discovery offers new insights into the environment in which brain tumors grow and sets the stage for future studies seeking to improve treatment outcomes.
-
NewsNext-generation microbiome medicine may revolutionize the treatment of Parkinson’s and similar disorders
Scientists have engineered the probiotic bacterium Escherichia coli Nissle 1917 as a drug-delivery system that continuously produces and delivers the gold-standard Parkinson’s drug Levodopa, which is converted to dopamine in the brain. E. coli Nissle strain was chosen for its century-long record of safely treating gastrointestinal disorders in humans.
-
NewsNew bioelectroceutical platform triggers dual cell death, reverses immunosuppression in colorectal cancer
Scientists have developed a new “microbial fuel cell” platform that integrates electrogenic bacteria with piezoelectric nanoparticles to cooperatively eradicate colorectal tumors, reverse immunosuppression, and remodel the gut microbiome.
-
NewsBacterial scents behind oak tree decline may be luring deadly beetles
The deadly decline of Britain’s native oak trees may be driven by an unexpected accomplice: their own smell. Scientists have discovered that trees affected by Acute Oak Decline (AOD) emit distinct odours that are highly attractive to the beetle Agrilus biguttatus, a key contributor to the decline.
-
NewsNew blueprint for nature’s carbon-capturing nanomachines revealed
Researchers have uncovered how bacterial organelles assemble, opening new routes for bioengineering and climate innovation. The team has unveiled the most detailed picture yet of how bacteria construct microscopic compartments known as carboxysomes – natural nanomachines that play a vital role in capturing and converting carbon dioxide (CO₂).
-
NewsNew test could allow for more accurate Lyme disease diagnosis
Researchers have developed a new way to detect the Lyme disease bacterium Borrelia burgdorferi, allowing for faster and more accurate diagnosis.
-
NewsNew DNA analysis approach could transform understanding of disease evolution
By adapting techniques originally used to study ancient DNA from archaeological specimens, researchers were able to recover genetic information from nearly century-old medical samples.
-
NewsManganese is Lyme disease bacterium’s double-edged sword
For decades, Lyme disease has frustrated both physicians and patients alike. Caused by the corkscrew-shaped bacterium Borrelia burgdorferi, the infection, if left untreated, can linger for months, leading to fever, fatigue and painful inflammation. Source: U.S. Centers for Disease Control and Prevention This digitally colorized scanning electron microscopic ...
-
NewsImaging reveals bacterial symbionts in the ovaries of tiny, aquatic crustaceans
Researchers have imaged a heritable form of bacterial symbiosis inside the reproductive system of tiny crustaceans known as ostracods. Bacteria from the genus Cardinium live inside the egg cells and tissues of ostracod ovaries, transmitted from mothers to offspring.
-
NewsScientists find way to find the gut microbiome into a longevity factory
A team of researchers has found a way to turn the bacteria living in the digestive tracts of animals into factories that can produce compounds that promote longevity in their hosts—showing a potential new drug development strategy.